Eli Lilly & Co. (LLY)
1004.92
-1.78
(-0.18%)
USD |
NYSE |
May 15, 16:00
1003.24
-1.68
(-0.17%)
After-Hours: 20:00
Eli Lilly Research and Development Expense (Quarterly) : 3.51B for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.495B |
| Merck & Co., Inc. | 11.98B |
| Pfizer Inc. | 2.452B |
| Bristol Myers Squibb Co. | 2.238B |
| Nektar Therapeutics | 35.68M |